These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 12324506)

  • 21. Homogenous IgA monomers, dimers, trimers and tetramers from the same IgA myeloma serum.
    Vaerman JP; Langendries A; Vander Maelen C
    Immunol Invest; 1995 May; 24(4):631-41. PubMed ID: 7622199
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-secretory or low-secretory myeloma with intracellular kappa chains. Report of six cases and review of the literature.
    Turesson I; Grubb A
    Acta Med Scand; 1978; 204(6):445-51. PubMed ID: 104550
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Polymeric (presumed tetrameric) lambda Bence Jones proteinemia without proteinuria in a patient with multiple myeloma.
    Hom BL
    Am J Clin Pathol; 1984 Nov; 82(5):627-9. PubMed ID: 6437210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel approach for the chromatographic purification and peptide mass fingerprinting of urinary free light chains.
    Mali BC; Badgujar SB; Shukla KK; Bhanushali PB
    Int J Biol Macromol; 2017 Feb; 95():331-339. PubMed ID: 27888009
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Analysis of the relationship of heavy/light chain pairs of immunoglobulin (Hevylite) to the results of gel electrophoresis and nefelometric examination of serum proteins at the time of multiple myeloma diagnosis].
    Ščudla V; Lochman P; Pika T; Zapletalová J; Minařík J; Bačovský J
    Cas Lek Cesk; 2015; 154(6):292-302. PubMed ID: 26750626
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Evaluation of the clinical relevance of serum measurements of free-light chains in patients with multiple myeloma].
    Shimizu K; Itoh J; Sugiura I; Tsushita K; Kosugi H; Nagura E
    Rinsho Ketsueki; 2006 Apr; 47(4):303-9. PubMed ID: 16715965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interference of polyclonal free light chains with identification of Bence Jones proteins.
    Hess PP; Mastropaolo W; Thompson GD; Levinson SS
    Clin Chem; 1993 Aug; 39(8):1734-8. PubMed ID: 8353965
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multiple myeloma with serum IgG kappa and Bence Jones lambda biclonal gammopathy.
    Finco B; Schiavon R
    Clin Chem; 1987 Jul; 33(7):1305-6. PubMed ID: 3109785
    [No Abstract]   [Full Text] [Related]  

  • 29. Restricted electrophoretic heterogeneity of immunoglobulin light chains in urine: a cause for confusion with Bence Jones protein.
    MacNamara EM; Aguzzi F; Petrini C; Higginson J; Gasparro C; Bergami MR; Bianchi G; Whicher JT
    Clin Chem; 1991 Sep; 37(9):1570-4. PubMed ID: 1909942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tetramer Bence Jones protein in the immunoproliferative diseases. Angioimmunoblastic lymphadenopathy, primary amyloidosis, and multiple myeloma.
    Kosaka M; Iishi Y; Okagawa K; Saito S; Sugihara J; Muto Y
    Am J Clin Pathol; 1989 Jun; 91(6):639-46. PubMed ID: 2499179
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of immunoglobulin light chain dimers on the results of the quantitative nephelometric assay.
    Li C; Geng H; Yang Z; Zhong R
    Clin Lab; 2011; 57(1-2):53-7. PubMed ID: 21391465
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Double Bence Jones proteinuria.
    Kanoh T; Yago K
    Arch Pathol Lab Med; 1990 Sep; 114(9):991-4. PubMed ID: 2117911
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of serum free light chain and urine electrophoresis for the detection of the light chain component of monoclonal immunoglobulins in light chain and intact immunoglobulin multiple myeloma.
    Dejoie T; Attal M; Moreau P; Harousseau JL; Avet-Loiseau H
    Haematologica; 2016 Mar; 101(3):356-62. PubMed ID: 26635032
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Detection of Bence-Jones protein by isoelectric focussing of unconcentrated urine followed by nitrocellulose blotting and immunoperoxidase staining.
    Norden AG; Fulcher LM; Flynn FV
    Clin Chim Acta; 1985 Dec; 153(3):149-56. PubMed ID: 3935344
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Quantitation of serum free light chains does not compensate for serum immunofixation only when screening for monoclonal gammopathies.
    Böer K; Deufel T
    Clin Chem Lab Med; 2009; 47(9):1109-15. PubMed ID: 19728853
    [TBL] [Abstract][Full Text] [Related]  

  • 36. κ and λ urine free light chains: a new method for quantification.
    Giussani M; Ciniselli CM; Macciotta A; Panella R; Verderio P; Bonini C; Morelli D
    Tumori; 2020 Dec; 106(6):457-463. PubMed ID: 31955649
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Kidney failure as an unusual initial presentation of biclonal gammopathy (IgD multiple myeloma associated with light chain disease)--a case report.
    Rabrenović V; Mijušković Z; Marjanović S; Rabrenović M; Jovanović D; Antić S; Ignjatović L; Petrović M; Pilcević D
    Vojnosanit Pregl; 2015 Feb; 72(2):196-9. PubMed ID: 25831916
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Light chain disease and massive proteinuria.
    Lessard F; Bannon P; Lepage R; Joly JG
    Clin Chem; 1985 Mar; 31(3):475-7. PubMed ID: 3918811
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoglobulin free light chain dimers in human diseases.
    Kaplan B; Livneh A; Sela BA
    ScientificWorldJournal; 2011 Mar; 11():726-35. PubMed ID: 21442150
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.